PTSD Trial, Recruiting NCT05310097 Sponsor: Boston University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05310097
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with PTSD, confirmed through a structured clinical interview called the Clinician Administered PTSD Scale (based on standard psychiatric guidelines).
  • People who are taking psychiatric medication, as long as the dose has been stable for the past four weeks.
  • People who have served in the military (veterans).

Who may not be able to join:

  • People who have a current diagnosis of unstable bipolar disorder, a history of psychosis (past or present), or a brain-based condition affecting thinking and behaviour.
  • People who are currently experiencing thoughts of suicide or harming others, with a specific plan or intention to act on those thoughts.
  • People who currently have a moderate or severe substance use disorder, meaning four or more diagnostic symptoms of substance use problems are present according to standard psychiatric guidelines.
  • People who have previously received a specific type of therapy for PTSD called Cognitive Processing Therapy (CPT), or who are currently receiving any other therapy for PTSD.
  • People whose thinking and memory abilities score below the 10th percentile on a standard cognitive assessment test called the Montreal Cognitive Assessment.
  • People with a history of moderate or severe traumatic brain injury, assessed using a specific identification method and military health guidelines.
  • People whose verbal memory ability scores more than one standard deviation above the average population score on a specific memory test called the California Verbal Learning Test (Third Edition) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph Carpenter, PhD MA, VA Boston Healthcare System, BUSM Psychiatry Dept.

Phone: 617-435-5319

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University
Registry
ClinicalTrials.gov
Start date
4 January 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mid-treatment Memory of therapy content assessed by the Therapy Recall Task; Post-treatment Memory of therapy content assessed by the Therapy Recall Task; Follow-up Memory of therapy content assessed by the Therapy Recall Task; Feasibility assessed by mean CPT Adherence; Feasibility assessed by mean CPT Competence; Feasibility assessed by the Memory Support Rating Scale (MSRS); Treatment acceptability after Session 1 assessed by the Credibility and Expectancy (CEQ) questionnaire; Mid-treatment acceptability assessed by the Working Alliance Inventory Short-Revised (WAI-R); Post-treatment accept...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov